Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis
This study indicates that fluvastatin has the potential to reverse TAX resistance in lung cancer, and the results of multi-omics analysis provide a theoretical basis for the exploration of potential therapeutic targets in the future.
Authors
- 佳苗 清水
- Xueting Li (ORCID: https://orcid.org/0009-0004-9505-9589)
- Juan Tang
- Hongyu Xu
- Zedong Du
Institutions
- Fourth People's Hospital of Sichuan Province (CN)
- Sichuan Cancer Hospital (CN)
- Chengdu Second People's Hospital (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/dddt.s579427
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00